Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hangzhou Dac Biotechnology Co., Ltd.

Clinical trials sponsored by Hangzhou Dac Biotechnology Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1

First patients to test new cancer drug DXC014 in groundbreaking trial

Disease control Not yet recruiting

This is the first-ever study in humans of a new drug called DXC014, designed for people with advanced solid tumors like lung cancer, melanoma, and prostate cancer. The main goal is to find a safe dose and understand how the body processes the drug. Researchers will also look for …

Phase: PHASE1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC